These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9164372)

  • 21. [Cardioversion in atrial fibrillation].
    Kuck KH
    Z Kardiol; 1994; 83 Suppl 5():59-62. PubMed ID: 7846946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines and clinical practice: anticoagulant therapy and cardioversion in atrial fibrillation].
    Callegari S; Pini M; Andreoli L
    G Ital Cardiol; 1999 Oct; 29(10):1157-63. PubMed ID: 10546125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of direct current cardioversions for atrial arrhythmia.
    Johnston SD; Trouton TG; Wilson C
    Ulster Med J; 1998 May; 67(1):19-24. PubMed ID: 9652194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological cardioversion of isolated atrial fibrillation: recovery of atrial mechanical function and correlation with duration of arrhythmia].
    Bellandi F; Dabizzi RP; Mugnaioni G; Cantini F; Palchetti R
    G Ital Cardiol; 1997 Oct; 27(10):1029-35. PubMed ID: 9410773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
    Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical challenge of the atrial fibrillation].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2007; 124(2):361-78. PubMed ID: 18069601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques.
    Andraghetti A; Scalese M
    Europace; 2001 Jan; 3(1):4-9. PubMed ID: 11271950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atrial fibrillation: always cardioversion? No].
    Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
    Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
    Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F
    Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary edema following electrical cardioversion of atrial fibrillation.
    Mayosi BM; Commerford PJ
    Chest; 1996 Jan; 109(1):278-80. PubMed ID: 8549199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electric cardioversion in the emergency service. Experience in 1000 cases].
    Sánchez Díaz CJ; González Carmona VM; Ruesga Zamora E; Monteverde Grether CA
    Arch Inst Cardiol Mex; 1987; 57(5):387-94. PubMed ID: 2962550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial reservoir and active transport function after cardioversion of chronic atrial fibrillation.
    Ito Y; Arakawa M; Noda T; Miwa H; Kagawa K; Nishigaki K; Fujiwara H
    Heart Vessels; 1996; 11(1):30-8. PubMed ID: 9119803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral blood flow before and after cardioversion of atrial fibrillation.
    Petersen P; Kastrup J; Videbaek R; Boysen G
    J Cereb Blood Flow Metab; 1989 Jun; 9(3):422-5. PubMed ID: 2715212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electric cardioversion of atrial fibrillation resulting in pulmonary oedema in patient with apical hypertrophic cardiomyopathy.
    Nawrocka I; Kaczyńska A; Abramczyk P
    Pol Merkur Lekarski; 2015 May; 38(227):278-9. PubMed ID: 26039023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamics and echocardiograms before and after cardioversion of atrial fibrillation to normal sinus rhythm.
    Orlando JR; van Herick R; Aronow WS; Olson HG
    Chest; 1979 Nov; 76(5):521-6. PubMed ID: 498823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternations in atrial natriuretic peptide release after DC cardioversion of non-valvular chronic atrial fibrillation.
    Arakawa M; Miwa H; Noda T; Ito Y; Kambara K; Kagawa K; Nishigaki K; Kano A; Hirakawa S
    Eur Heart J; 1995 Jul; 16(7):977-85. PubMed ID: 7498215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamic effect of cardioversion in patients after mitral commissurotomy].
    Mazurowa A; Tracz W; Skotnicki S
    Kardiol Pol; 1969; 12(1):59-62. PubMed ID: 5781306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.